Triple
T6098297
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Entrez system |
E135930
|
entity |
| Predicate | hasPart |
P35
|
FINISHED |
| Object |
PubChem BioAssay
PubChem BioAssay is a public database of biological activity results from high-throughput screening and other assays, used to link chemical substances with their biological effects.
|
E569125
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: PubChem BioAssay | Statement: [Entrez system, hasPart, PubChem BioAssay]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: PubChem BioAssay Context triple: [Entrez system, hasPart, PubChem BioAssay]
-
A.
PaperChem
PaperChem is a specialized database focused on chemical and materials science information related to paper and pulp research, accessible through the Engineering Village platform.
-
B.
Reaxys
Reaxys is a comprehensive chemistry research database and workflow tool that provides curated information on chemical substances, reactions, and properties for scientists and researchers.
-
C.
SciFinder-n
SciFinder-n is a comprehensive research discovery platform from Chemical Abstracts Service that enables scientists to search and analyze chemical substances, reactions, literature, and related scientific data.
-
D.
ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals is an international regulatory guideline that outlines the nonclinical safety studies needed to support the development and approval of anticancer drugs in humans.
-
E.
ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals is an international guideline that outlines the nonclinical safety testing requirements for biotechnological products such as therapeutic proteins and monoclonal antibodies to support their clinical development and marketing authorization.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: PubChem BioAssay Triple: [Entrez system, hasPart, PubChem BioAssay]
Generated description
PubChem BioAssay is a public database of biological activity results from high-throughput screening and other assays, used to link chemical substances with their biological effects.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: PubChem BioAssay Target entity description: PubChem BioAssay is a public database of biological activity results from high-throughput screening and other assays, used to link chemical substances with their biological effects.
-
A.
PaperChem
PaperChem is a specialized database focused on chemical and materials science information related to paper and pulp research, accessible through the Engineering Village platform.
-
B.
Reaxys
Reaxys is a comprehensive chemistry research database and workflow tool that provides curated information on chemical substances, reactions, and properties for scientists and researchers.
-
C.
SciFinder-n
SciFinder-n is a comprehensive research discovery platform from Chemical Abstracts Service that enables scientists to search and analyze chemical substances, reactions, literature, and related scientific data.
-
D.
ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals is an international regulatory guideline that outlines the nonclinical safety studies needed to support the development and approval of anticancer drugs in humans.
-
E.
ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals is an international guideline that outlines the nonclinical safety testing requirements for biotechnological products such as therapeutic proteins and monoclonal antibodies to support their clinical development and marketing authorization.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0087cd3c48190b459848c72d84eb1 |
completed | March 22, 2026, 3:19 p.m. |
| NER | Named-entity recognition | batch_69c05a9a02888190ac201acd14c3fc31 |
completed | March 22, 2026, 9:09 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c1254365708190b8feb95dfb2b730d |
completed | March 23, 2026, 11:34 a.m. |
| NEDg | Description generation | batch_69c125d888cc819092b765d47f1d9f9f |
completed | March 23, 2026, 11:36 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69c126f308988190ab6cb6c79ea12877 |
completed | March 23, 2026, 11:41 a.m. |
Created at: March 22, 2026, 4:12 p.m.